Funding to support new innovative medical solutions that will better equip Canada’s medical system and bring important benefits to Canadians TORONTO, ON — The pandemic has shown how important it… Read More
Nirsevimab is the first investigational long-acting antibody designed for all infants to help protect against respiratory syncytial virus (RSV) throughout their first RSV season with a single dose Health Canada has accepted… Read More
Innovate BC and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) are providing a combined total of $2 million in research and development funding to help… Read More
OTTAWA, ON — BioTalent Canada today announced the recipients of its inaugural I.D.E.A.L. Bioscience Employer™ designation. The I.D.E.A.L. Recognition Program recognizes organizations in the Canadian bio-economy who embody the principles of… Read More
Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund. INOVAIT is a pan-Canadian network funded by the Government of… Read More
